PFAM Search:   
       by Pfam accession/ID, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  

Full view: branches of nodes matching the query are shown completely (Compact view)

(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Clan: Ig (577)
(-)
Family: A2M (13)
(-)
Anopheles gambiae (African malaria mosquito) (1)
2PN5A:611-702CRYSTAL STRUCTURE OF TEP1R
(-)
Homo sapiens (Human) (12)
2WIIB:748-844COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4
2WINH:748-844; H:748-844; H:748-844; H:748-844C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
2XWBD:748-844; D:748-844CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
2XWJH:748-844; H:748-844; H:748-844; H:748-844CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
3L3OE:748-844; E:748-844STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3C
3L5NB:748-844STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3B
3NMSB:748-844STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT C3C
3OHXE:748-844; E:748-844MOLECULAR BASIS FOR COMPLEMENT RECOGNITION AND INHIBITION DETERMINED BY CRYSTALLOGRAPHIC STUDIES OF THE STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) BOUND TO C3C AND C3B
3KLSB:772-859; B:772-859STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
3KM9B:772-859; B:772-859STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
3PRXC:772-859; C:772-859STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
3PVMC:772-859; C:772-859STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
(-)
Family: C1-set (338)
(-)
Bos taurus (Bovine) (2)
2XFXB:12-92; A:189-271CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA
3L9RH:11-91; H:11-91; H:11-91; H:11-91; G:194-273; G:194-273; G:194-273; G:194-273CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
(-)
Gallus gallus (Chicken) (2)
3P73B:11-92; A:188-267CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
3P77B:11-92; A:188-267CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
(-)
Homo sapiens (Human) (218)
1W72D:187-271; D:187-271; E:11-92; E:11-92CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1JF1A:188-271; B:11-92CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
1JHTA:188-271; B:11-92CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.
1LP9H:188-271; H:188-271; I:11-92; I:11-92XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1OGAA:188-271; B:11-92; E:129-222A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1P7QA:188-271; B:11-92CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1QEWA:188-271HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1QR1D:188-271; D:188-271; E:11-92; E:11-92POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1QRNA:188-271; B:11-92CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSFA:188-271; B:11-92STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1S8DA:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A
1S9WA:188-271; B:11-92CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2
1S9YA:188-271; B:11-92CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2
1T1WA:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V
1T1XA:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L
1T1YA:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V
1T1ZA:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A
1T20A:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I
1T21A:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL
1T22A:188-271; B:11-92STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL
1TVHD:188-271; D:188-271; E:11-92; E:11-92CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
2JCCH:188-271; H:188-271; I:11-92; I:11-92AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2P5EA:188-271; B:11-92CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2P5WA:188-271; B:11-92CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2UWEH:188-271; H:188-271; I:11-92; I:11-92LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2V2WD:188-271; D:188-271; E:11-92; E:11-92T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
2V2XD:188-271; D:188-271; E:11-92; E:11-92T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
2VLJA:188-271; B:11-92THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLKA:188-271; B:11-92THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLLD:188-271; D:188-271; E:11-92; E:11-92THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLRF:188-271; F:188-271; G:11-92; G:11-92THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2X4ND:187-270; D:187-270; E:11-92; E:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
2X4OD:188-271; D:188-271; E:11-92; E:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
2X4PD:188-271; D:188-271; E:11-92; E:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
2X4QD:188-271; D:188-271CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
2X4RD:188-271; D:188-271; E:11-92; E:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
2X4SD:188-271; D:188-271CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
2X4TD:188-271; D:188-271CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
2X70D:187-270; D:187-270; E:11-92; E:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
3KLAD:188-271; D:188-271; E:11-92; E:11-92CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
3MGOJ:188-271; J:188-271; J:188-271; J:188-271; K:11-92; K:11-92; K:11-92; K:11-92CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
3MGTJ:188-271; J:188-271; J:188-271; J:188-271; K:11-92; K:11-92; K:11-92; K:11-92CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
3MR9A:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT
3MRBA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT
3MRCA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT
3MRDA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT
3MREA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE
3MRFA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT
3MRGA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE
3MRHA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT
3MRIA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT
3MRJA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT
3MRKA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE
3MRLA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT
3MRMA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE
3MRNA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE
3MROA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRPA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRQA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT
3MRRA:188-271; B:11-92CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE
3MYJD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
3O3AD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
3O3BD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
3O3DD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
3O3ED:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
3PWJD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT
3PWLD:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
3PWND:188-271; D:188-271; E:11-92; E:11-92HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
3PWPA:188-271; B:11-92THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3QDGA:188-271; B:11-92THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJA:188-271; B:11-92THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMA:188-271; B:11-92THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEQA:188-271; B:11-92THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2XPGA:185-271; B:11-92CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
1Q94D:185-271; D:185-271; E:11-92; E:11-92STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1QVOD:185-271; D:185-271; E:11-92; E:11-92STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1X7QA:185-271; B:11-92CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE
3QZWD:187-271; D:187-271; E:11-92; E:11-92PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
1M05C:186-271; C:186-271; D:11-92; D:11-92HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1XR8A:185-271; B:11-92CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1XR9A:185-271; B:11-92CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1JGDA:186-271; B:11-92HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
1JGEA:186-271; B:11-92HLA-B*2705 BOUND TO NONA-PEPTIDE M9
1K5NA:186-271; B:11-92HLA-B*2709 BOUND TO NONA-PEPTIDE M9
1OF2A:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1UXWA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1W0VA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
1W0WA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
3LV3A:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)
1XH3A:186-271; B:11-92CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501
1ZHKA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZHLA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1ZSDA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY
2NW3A:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2NX5Q:186-271; Q:186-271; Q:186-271; Q:186-271; R:11-92; R:11-92; R:11-92; R:11-92CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3KWWA:186-271; B:11-92CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE
3KXFK:186-271; K:186-271; K:186-271; K:186-271; L:11-92; L:11-92; L:11-92; L:11-92CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER
3LKNA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN
3LKOA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN
3LKPA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN
3LKRA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN
3LKSA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN
3MV8A:186-271; B:11-92CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA-B*3501/HPVG
3MV9A:186-271; B:11-92CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA-B*3501/HPVG
3LN4A:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2
3LN5A:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE
1M6OA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE
1SYSA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY
1SYVA:186-271; B:11-92HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF
3KPLA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPMA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPNA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPOA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPPA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3KPQA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE
3KPRF:186-271; F:186-271; G:11-92; G:11-92CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3L3DA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3GA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3JA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
3L3KA:186-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
2RFXA:185-271; B:11-92CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF
1QQDA:187-271; B:11-92CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
1JWSB:103-185; A:93-175CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
1JWUB:103-185; A:93-175CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
1KG0B:103-185; A:93-175STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
1KLGB:103-185; A:93-175CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1KLUB:103-185; A:93-175CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
1LO5B:103-185; A:93-175CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
1SEBF:103-185; F:103-185; E:93-175; E:93-175COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1SJEB:103-185; A:93-175HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
1SJHB:103-185; A:93-175HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
1T5WE:103-185; E:103-185; D:93-175; D:93-175HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
1T5XB:103-185; A:93-175HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
2OJEF:103-185; F:103-185; E:93-175; E:93-175MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
2XN9E:103-185; D:93-175; B:129-222CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
3L6FB:103-185; A:93-175STRUCTURE OF MHC CLASS II MOLECULE HLA-DR1 COMPLEXED WITH PHOSPHOPEPTIDE MART-1
3PDOB:103-185; A:93-175CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120
3PGCE:103-185; E:103-185; D:93-175; D:93-175CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120, FLIPPED PEPTIDE ORIENTATION
3PGDE:103-185; E:103-185; D:93-175; D:93-175CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120, CANONICAL PEPTIDE ORIENTATION
2SEBB:103-185; A:93-175X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
3O6FF:132-214; F:132-214; E:93-175; E:93-175; H:129-222; H:129-222CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
1YMMB:103-185; A:93-175; E:133-226TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
1JNJA:11-92NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-MICROGLOBULIN
1KPRD:11-92; D:11-92; C:186-271; C:186-271THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1KTLD:11-92; D:11-92; C:186-271; C:186-271THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1LDSA:11-92CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2-MICROGLOBULIN
1MHED:11-92; D:11-92; C:186-271; C:186-271THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1OGTB:11-92CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
1ONQD:11-92; D:11-92; C:193-274; C:193-274CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1PY4D:11-92; D:11-92; D:11-92; D:11-92BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOID FORMATIONS
1QLFB:11-92MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
1R3HH:8011-8092; H:8011-8092; H:8011-8092; H:8011-8092CRYSTAL STRUCTURE OF T10
1TMCB:11-92THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN
1UQSB:11-92; A:194-274THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID
1VGKB:11-92THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION
1XZ0D:11-92; D:11-92; C:193-274; C:193-274CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1YDPB:11-92; A:186-2711.9A CRYSTAL STRUCTURE OF HLA-G
1YPZD:11-92; D:11-92IMMUNE RECEPTOR
1ZS8J:11-92; J:11-92; J:11-92; J:11-92; J:11-92CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1ZT4D:11-92; D:11-92; C:194-274; C:194-274THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE
1ZVSE:11-92; E:11-92CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
2PO6F:11-92; F:11-92; E:194-274; E:194-274CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2-MICROGLOBULIN, NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2VB5A:11-92SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN
2X89G:11-92; G:11-92; G:11-92; G:11-92STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2XKSA:11-92PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2XKUA:11-92PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2YXFA:11-92THE HIGH RESOLUTION CRYSTAL STRUCTURE OF BETA2-MICROGLOBULIN UNDER PHYSIOLOGICAL CONDITIONS
2Z9TA:11-92CRYSTAL STRUCTURE OF THE HUMAN BETA-2 MICROGLOBULIN MUTANT W60G
3JTSH:11-92; H:11-92; H:11-92GY9-MAMU-A*02-HB2M
3KYNB:11-92; A:186-271CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE
3LOWB:11-92; B:11-92CRYSTAL STRUCTURE OF BETA 2 MICROGLOBULIN DOMAIN-SWAPPED DIMER
3LOZD:1-6; D:1-6; D:1-6; D:1-6CRYSTAL STRUCTURE OF BETA 2 MICROGLOBULIN AMYLOIDOGENIC SEGMENT LSFSKD
3M17H:11-92; H:11-92; H:11-92; H:11-92; G:185-264; G:185-264; G:185-264; G:185-264CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
3M1BH:11-92; H:11-92; H:11-92; H:11-92; G:185-264; G:185-264; G:185-264; G:185-264CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
3MYZB:11-92; B:11-92PROTEIN INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T
3MZTF:11-92; F:11-92; F:11-92; F:11-92; F:11-92; F:11-92PROTEIN-INDUCED PHOTOPHYSICAL CHANGES TO THE AMYLOID INDICATOR DYE, THIOFLAVIN T
3NA4A:11-92D53P BETA-2 MICROGLOBULIN MUTANT
3O4LB:11-92; A:188-271GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3OV6A:1011-1092; A:195-275CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE)
3OX8E:11-92; E:11-92CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
3OXRB:11-92CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27
3OXSB:11-92CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27
3QDAA:11-92CRYSTAL STRUCTURE OF W95L BETA-2 MICROGLOBULIN
3LQZA:93-175; B:100-183CRYSTAL STRUCTURE OF HLA-DP2
1JK8A:93-175; B:102-185CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
1S9VD:93-175; D:93-175; E:102-185; E:102-185CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
1ZGLJ:93-175; J:93-175; J:93-175; J:93-175; K:103-189; K:103-189; K:103-189; K:103-189; V:132-225; V:132-225; V:132-225; V:132-225CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2Q6WD:93-175; D:93-175; E:103-190; E:103-190THE STRUCTURE OF HLA-DRA, DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
2WBJE:93-175; E:93-175TCR COMPLEX
2QEJB:353-444; B:353-444CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
2WQRB:450-536; B:450-536; B:450-536; B:450-536; B:450-536; B:450-536THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC
2Y7QD:450-536; D:450-536; D:450-536; D:450-536; D:450-536; D:450-536THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
1L6XA:352-437; A:352-437FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C
1OQXB:352-437; B:352-437; B:352-437; B:352-437G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C
1T83B:352-437; B:352-437; B:352-437; B:352-437CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1T89B:352-437; B:352-437; B:352-437; B:352-437CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
2QL1A:352-437; A:352-437STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT
1MIML:115-202IGG FAB FRAGMENT (CD25-BINDING)
1UCBL:118-205STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ)
1JE6A:189-272STRUCTURE OF THE MHC CLASS I HOMOLOG MICB
2NY1D:3141-3223; C:2121-2208HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3D:3141-3223; C:2121-2208HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXYD:3140-3223; C:2121-2208HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
1JVKB:124-211; B:124-211THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
3MNZA:119-206CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION
2WNGA:228-312; A:228-312COMPLETE EXTRACELLULAR STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
1KGCE:132-225IMMUNE RECEPTOR
2NTSP:132-225CRYSTAL STRUCTURE OF SEK-HVB5.1
2NW2B:132-225CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2XNAB:129-222CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
3O8XD:126-219RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WD:126-219RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
1T7WA:191-272ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 400
1T7XA:191-272ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400
1T7YA:191-272ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200, NO GLYCEROL
1T7ZA:191-272ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG NO PEG, NO GLYCEROL
1T80A:191-272ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 200
1ZAGD:191-272; D:191-272; D:191-272; D:191-272HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
(-)
Macaca mulatta (Rhesus macaque) (2)
3JTTH:12-93; H:12-93; H:12-93; G:187-271; G:187-271; G:187-271CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
3JTSG:187-271; G:187-271; G:187-271GY9-MAMU-A*02-HB2M
(-)
Murid herpesvirus 1 (strain K181) (MuHV-1) (Mouse cytomegalovirus) (1)
1U58A:151-234CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144
(-)
Mus musculus (Mouse) (118)
2OJZM:119-206; M:119-206ANTI-DNA ANTIBODY ED10
2OK0L:119-206FAB ED10-DNA COMPLEX
1JPFB:11-92; A:189-271CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JPGB:11-92; A:189-271CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1JUFB:1011-1092; A:189-271STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B, COMPLEXED TO H2-DB
1KJ3M:11-92; M:11-92; I:188-271; I:188-271MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
1LD9E:11-92; E:11-92; D:189-268; D:189-268THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1LDPL:11-92; H:189-271CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1LEGB:11-92; A:188-271CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE
1LEKB:11-92; A:188-271CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8
1LK2B:11-92; A:188-2711.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE
1MHCE:11-92; E:11-92; D:188-271; D:188-271MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1N3NH:11-92; H:11-92; H:11-92; H:11-92; G:189-271; G:189-271; G:189-271; G:189-271CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1N59D:11-92; D:11-92; C:188-271; C:188-271CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1N5AK:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1NAML:11-92; H:188-271MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1NANP:11-92; P:11-92; L:188-271; L:188-271MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
1NEZB:11-92; A:188-271THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY
1OSZB:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1P4LB:11-92CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB
1PQZB:11-92MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144
1QO3B:11-92; A:188-271COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
1RJYE:11-92; E:11-92; D:188-271; D:188-271MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RJZE:11-92; E:11-92; D:188-271; D:188-271MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1RK0B:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1RK1B:11-92; A:188-271MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1S7QB:11-92; A:188-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7RE:11-92; E:11-92; D:188-271; D:188-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7SB:11-92; A:188-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7TE:11-92; E:11-92; D:188-271; D:188-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7UK:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7VE:11-92; E:11-92; D:189-271; D:189-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7WK:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1S7XK:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1T0NE:11-92; E:11-92; D:188-271; D:188-271CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1U58B:11-92CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144
1VACB:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
1VADB:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1WBXB:11-92; A:189-271CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBYB:11-92; A:189-271CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1WBZD:11-92; D:11-92; C:188-271; C:188-271CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1YN6B:11-92; A:189-271CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE
1Z5LD:11-92; D:11-92; C:194-275; C:194-275STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1ZHBK:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA-MONOOXIGENASE
1ZHNB:11-92; A:194-275CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE
1ZT7D:11-92; D:11-92; C:188-271; C:188-271CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
2MHAD:11-92; D:11-92; C:188-270; C:188-270CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
2OL3L:11-92; H:188-271CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2Q7YD:11-92; D:11-92; C:194-275; C:194-275STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
2VAAB:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
2VABB:11-92; A:188-271MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
2VE6K:11-92; K:11-92; K:11-92; K:11-92; J:189-271; J:189-271; J:189-271; J:189-271CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
2ZOKH:11-92; H:11-92; H:11-92; H:11-92; G:189-271; G:189-271; G:189-271; G:189-271CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
2ZOLD:11-92; D:11-92; C:189-271; C:189-271CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
2ZSVD:11-92; D:11-92; C:188-271; C:188-271CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
2ZSWH:11-92; H:11-92; H:11-92; H:11-92; G:188-271; G:188-271; G:188-271; G:188-271CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
3L3HB:11-92; A:189-271X-RAY CRYSTAL STRUCTURE OF THE F6A MUTANT OF INFLUENZA A ACID POLYMERASE EPITOPE PA224 BOUND TO MURINE H2-DB MHC
3PQYQ:11-92; Q:11-92; Q:11-92; Q:11-92; P:189-271; P:189-271; P:189-271; P:189-271CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
3MA7C:194-275; C:194-275CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
3O8XA:194-275RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3O9WA:194-275RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3QUXA:194-275STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3QUYA:194-275STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX
3QUZA:194-275STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
1K8IA:104-183; B:102-185CRYSTAL STRUCTURE OF MOUSE H2-DM
1QLFA:189-271MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
2QRIB:188H-271H; B:188H-271HCRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB WT, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE.
2QRSB:188H-271H; B:188H-271HCRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84A, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE.
2QRTB:188H-271H; B:188H-271HCRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C, BETA-2MICROGLOBULIN, AND OVALBUMIN-DERIVED PEPTIDE.
1VGKA:165-271THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, H-2KD AT 2.0 A RESOLUTION
1KT2C:93-175; C:93-175CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
1KTDC:93-175; C:93-175CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
1R5WC:93-175; C:93-175; D:130-212; D:130-212EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
3QIBA:93-175; B:103-185CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QIUA:93-175; B:103-185CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
3QIWA:93-175; B:103-185CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK
1LNUG:94-176; G:94-176; G:94-176; G:94-176; H:130-212; H:130-212; H:130-212; H:130-212CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
1MUJA:93-175; B:103-185CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
3MBEE:93-175; E:93-175; F:103-188; F:103-188TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
1JL4A:93-175; B:103-190CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1K2DA:93-175; B:103-190CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
1U3HG:93-175; G:93-175; H:103-189; H:103-189CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2P24A:93-175; B:203-293I-AU/MBP125-135
2PXYC:93-175; D:103-191CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2Z31C:93-175; D:103-190CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
2RGSB:352-436; B:352-436; B:352-436; B:352-436FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS
1KB5L:119-206MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
1KCSL:119-206CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1KCVL:119-206CRYSTAL STRUCTURE OF ANTIBODY PC282
1KENU:120-207; U:120-207INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
1MLBA:119-206MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
1NBYA:119-206CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
1NDMA:119-206CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
1ORQA:120-207X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
1ORSA:119-206X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
1PSKL:118-205THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
1JN6A:122-208; B:131-212CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNHG:121-207; G:121-207; G:121-207; G:121-207CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2QHRL:120-205CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
1R3HG:7189-7271; G:7189-7271; G:7189-7271; G:7189-7271CRYSTAL STRUCTURE OF T10
1NBZB:426-507CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
3OZ9H:126-220; L:119-206CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
1MPAH:134-215BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
2MPAH:134-215BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3NWMA:165H-271HCRYSTAL STRUCTURE OF A SINGLE CHAIN CONSTRUCT COMPOSED OF MHC CLASS I H-2KD, BETA-2MICROGLOBULIN AND A PEPTIDE WHICH IS AN AUTOANTIGEN FOR TYPE 1 DIABETES
1XGYI:126-207; I:126-207CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42-41L
1YNLH:125-206IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
1JGLL:119-206CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
1JNLL:119-206; H:127-221CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNNL:119-206; H:127-221CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1ZS8I:187-270; I:187-270; I:187-270; I:187-270; I:187-270CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1JGUH:126-207STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JGVH:126-207STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1T66H:131-212; H:131-212THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
1YPZC:189-271; C:189-271IMMUNE RECEPTOR
1NFDD:131-224; D:131-224AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
1SBBC:131-224; C:131-224T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SEB
2Q86D:125-214; D:125-214STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
(-)
Oryctolagus cuniculus (Rabbit) (1)
2VUOB:352-437; B:352-437; B:352-437; B:352-437CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT
(-)
Rattus norvegicus (Rat) (3)
1KJMB:11-92; A:186-271TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE
1KJVB:11-92TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE
1ZANL:120-207CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
(-)
Family: C2-set (18)
(-)
Homo sapiens (Human) (18)
1JL4D:100-178CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1RZJC:100-178HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1WIPB:292-363; B:292-363; B:292-363; B:292-363STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM
1WIQB:292-363; B:292-363; B:292-363; B:292-363STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM
2NXYB:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZB:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0B:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1B:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2B:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3B:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4B:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5C:1100-1178HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2QADF:100-178; F:100-178STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
3JWDD:1100-1178; D:1100-1178STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3JWOC:1100-1178STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3LQAC:100-176CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
1VCAB:109-197; B:109-197CRYSTAL STRUCTURE OF AN INTEGRIN-BINDING FRAGMENT OF VASCULAR CELL ADHESION MOLECULE-1 AT 1.8 ANGSTROMS RESOLUTION
1VSCB:109-195; B:109-195VCAM-1
(-)
Family: C2-set_2 (3)
(-)
Homo sapiens (Human) (3)
2PETA:119-217LUTHERAN GLYCOPROTEIN, N-TERMINAL DOMAINS 1 AND 2.
2PF6B:119-217; B:119-217LUTHERAN GLYCOPROTEIN, N-TERMINAL DOMAINS 1 AND 2
3O3UN:1124-1219CRYSTAL STRUCTURE OF HUMAN RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE)
(-)
Family: Herpes_glycop_D (1)
(-)
Human herpesvirus 1 (strain Patton) (HHV-1) (Human herpes simplex virus 1) (1)
1JMAA:57-181CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM
(-)
Family: I-set (67)
(-)
Caenorhabditis elegans (3)
1KOAA:6266-6355TWITCHIN KINASE FRAGMENT (C.ELEGANS), AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS
1WITA:3-92TWITCHIN IMMUNOGLOBULIN SUPERFAMILY DOMAIN (IGSF MODULE) (IG 18'), NMR, MINIMIZED AVERAGE STRUCTURE
1WIUA:3-92TWITCHIN IMMUNOGLOBULIN SUPERFAMILY DOMAIN (IGSF MODULE) (IG 18'), NMR, 30 STRUCTURES
(-)
Drosophila melanogaster (Fruit fly) (7)
2YD1A:140-227; A:140-227CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF DROSOPHILA RECEPTOR PROTEIN TYROSINE PHOSPHATASE DLAR
3PXJD:140-227; D:140-227; D:140-227; D:140-227; D:140-227; D:140-227; D:140-227; D:140-227TANDEM IG REPEATS OF DLAR
2VR9C:155-251; C:155-251; C:155-251; C:155-251; C:155-251; C:155-251DROSOPHILA ROBO IG1-2 (TETRAGONAL FORM)
2VRAD:155-251; D:155-251; D:155-251; D:155-251; D:155-251; D:155-251; D:155-251; D:155-251DROSOPHILA ROBO IG1-2 (MONOCLINIC FORM)
2V5MA:309-387; A:309-387STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
2V5RB:312-390; B:312-390; B:312-390; B:312-390STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
2V5SB:309-387; B:309-387; B:309-387; B:309-387STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
(-)
Homo sapiens (Human) (50)
3QQNB:2-110; B:2-110THE RETINAL SPECIFIC CD147 IG0 DOMAIN: FROM MOLECULAR STRUCTURE TO BIOLOGICAL ACTIVITY
3QR2B:2-110; B:2-110WILD TYPE CD147 IG0 DOMAIN
1WVZA:16-103SOLUTION STRUCTURE OF THE D2 DOMAIN OF THE FIBROBLAST GROWTH FACTOR
1RY7B:257-356; B:257-356CRYSTAL STRUCTURE OF THE 3 IG FORM OF FGFR3C IN COMPLEX WITH FGF1
2YR3A:12-98SOLUTION STRUCTURE OF THE FOURTH IG-LIKE DOMAIN FROM MYOSIN LIGHT CHAIN KINASE, SMOOTH MUSCLE
2KKQA:16-107SOLUTION NMR STRUCTURE OF THE IG-LIKE C2-TYPE 2 DOMAIN OF HUMAN MYOTILIN. NORTHEAST STRUCTURAL GENOMICS TARGET HR3158.
2YUVA:9-93SOLUTION STRUCTURE OF 2ND IMMUNOGLOBULIN DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
2YUZA:8-82SOLUTION STRUCTURE OF 4TH IMMUNOGLOBULIN DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
2YXMA:9-93CRYSTAL STRUCTURE OF I-SET DOMAIN OF HUMAN MYOSIN BINDING PROTEINC
1PD6A:213-298THE NMR STRUCTURE OF DOMAIN C2 OF HUMAN CARDIAC MYOSIN BINDING PROTEIN C
2K1MA:9-933D NMR STRUCTURE OF DOMAIN CC0 OF CARDIAC MYOSIN BINDING PROTEIN C (MYBPC)
2V6HA:156-256CRYSTAL STRUCTURE OF THE C1 DOMAIN OF CARDIAC MYOSIN BINDING PROTEIN-C
3MTRB:408-495; B:408-495CRYSTAL STRUCTURE OF THE IG5-FN1 TANDEM OF HUMAN NCAM
2JLLA:401-492; A:401-492CRYSTAL STRUCTURE OF NCAM2 IGIV-FN3II
2V5TA:211-298; A:211-298CRYSTAL STRUCTURE OF NCAM2 IG2-3
2VAJA:1-91CRYSTAL STRUCTURE OF NCAM2 IG1 (I4122 CELL UNIT)
2WIMB:211-294; B:211-294; B:211-294; B:211-294; B:211-294; B:211-294CRYSTAL STRUCTURE OF NCAM2 IG1-3
2XY1A:302-397; A:302-397CRYSTAL STRUCTURE OF NCAM2 IG3-4
2XY2A:115-198; A:115-198CRYSTAL STRUCTURE OF NCAM2 IG1-2
2XYCA:401-492; A:401-492CRYSTAL STRUCTURE OF NCAM2 IGIV-FN3I
3P3YA:337-425; A:337-425CRYSTAL STRUCTURE OF NEUROFASCIN HOMOPHILIC ADHESION COMPLEX IN SPACE GROUP P6522
3P40A:337-425; A:337-425CRYSTAL STRUCTURE OF NEUROFASCIN ADHESION COMPLEX IN SPACE GROUP P3221
1WWBX:298-377LIGAND BINDING DOMAIN OF HUMAN TRKB RECEPTOR
1WWCA:317-392NT3 BINDING DOMAIN OF HUMAN TRKC RECEPTOR
2YZ8A:460-544CRYSTAL STRUCTURE OF THE 32TH IG-LIKE DOMAIN OF HUMAN OBSCURIN (KIAA1556)
2WP3O:12-101; T:5-96CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX
2WWKO:12-101; T:5-96CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG F17R MUTANT COMPLEX
2WWMO:12-101; O:12-101; T:5-96; T:5-96CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN LIKE 1 IG COMPLEX IN SPACE GROUP P1
3KNBB:14-103; A:6-97CRYSTAL STRUCTURE OF THE TITIN C-TERMINUS IN COMPLEX WITH OBSCURIN-LIKE 1
2YD5A:135-225; A:135-225CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR
2YD8A:135-225; A:135-225CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR IN COMPLEX WITH SUCROSE OCTASULPHATE
2YD2A:135-222; A:135-222CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
2YD3A:135-219; A:135-219CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
2YD9A:232-308; A:232-308; A:232-308CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-3 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
2V9QA:262-266; A:262-266; A:262-266FIRST AND SECOND IG DOMAINS FROM HUMAN ROBO1
2V9RA:170-258; A:170-258FIRST AND SECOND IG DOMAINS FROM HUMAN ROBO1 (FORM 2)
2V9TA:68-165COMPLEX BETWEEN THE SECOND LRR DOMAIN OF SLIT2 AND THE FIRST IG DOMAIN FROM ROBO1
1WF5A:8-14SOLUTION STRUCTURE OF THE FIRST FN3 DOMAIN OF SIDEKICK-2 PROTEIN
1U2HA:20-110X-RAY STRUCTURE OF THE N-TERMINALLY TRUNCATED HUMAN APEP-1
1NCTA:1-89TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR
1NCUA:1-89TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR
1TNMA:1-89TERTIARY STRUCTURE OF AN IMMUNOGLOBULIN-LIKE DOMAIN FROM THE GIANT MUSCLE PROTEIN TITIN: A NEW MEMBER OF THE I SET
1YA5B:104-193; B:104-193; B:104-193; B:104-193CRYSTAL STRUCTURE OF THE TITIN DOMAINS Z1Z2 IN COMPLEX WITH TELETHONIN
2NZIB:102-192; B:102-192; B:102-192; B:102-192CRYSTAL STRUCTURE OF DOMAINS A168-A170 FROM TITIN
2Y9RT:5-96CRYSTAL STRUCTURE OF THE M10 DOMAIN OF TITIN
3LCYD:110-194; D:110-194; D:110-194; D:110-194; D:110-194; D:110-194; D:110-194; D:110-194TITIN IG TANDEM DOMAINS A164-A165
1RHFB:7-95; B:7-95CRYSTAL STRUCTURE OF HUMAN TYRO3-D1D2
1VCAB:1-88; B:1-88CRYSTAL STRUCTURE OF AN INTEGRIN-BINDING FRAGMENT OF VASCULAR CELL ADHESION MOLECULE-1 AT 1.8 ANGSTROMS RESOLUTION
1VSCB:1-88; B:1-88VCAM-1
3KVQA:667-754CRYSTAL STRUCTURE OF VEGFR2 EXTRACELLULAR DOMAIN D7
(-)
Meleagris gallopavo (Common turkey) (1)
1TLKA:42-132X-RAY STRUCTURE DETERMINATION OF TELOKIN, THE C-TERMINAL DOMAIN OF MYOSIN LIGHT CHAIN KINASE, AT 2.8 ANGSTROMS RESOLUTION
(-)
Mus musculus (Mouse) (4)
2O26Y:213-310; Y:213-310; Y:213-310; Y:213-310STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY
2NCMA:3-97NEURAL CELL ADHESION MOLECULE, NMR, 20 STRUCTURES
3NCMA:3-86NEURAL CELL ADHESION MOLECULE, MODULE 2, NMR, 20 STRUCTURES
3PXHA:135-225; A:135-225TANDEM IG DOMAINS OF TYROSINE PHOSPHATASE LAR
(-)
Rattus norvegicus (Rat) (2)
1QZ1A:195-286; A:195-286; A:195-286CRYSTAL STRUCTURE OF THE IG 1-2-3 FRAGMENT OF NCAM
2WV3A:93-188NEUROPLASTIN-55 BINDS TO AND SIGNALS THROUGH THE FIBROBLAST GROWTH FACTOR RECEPTOR
(-)
Family: ICAM_N (3)
(-)
Homo sapiens (Human) (3)
1MQ8C:1-88; C:1-88CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
1Z7ZI:1-88CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI
1ZXQA:1-90THE CRYSTAL STRUCTURE OF ICAM-2
(-)
Family: Ig_2 (52)
(-)
Drosophila melanogaster (Fruit fly) (3)
2V5MA:5-100STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
2V5RB:5-100; B:5-100STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
2V5SB:5-100; B:5-100STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY
(-)
Ectromelia virus (1)
3OQ3B:145-214STRUCTURAL BASIS OF TYPE-I INTERFERON SEQUESTRATION BY A POXVIRUS DECOY RECEPTOR
(-)
Enterobacteria phage RB49 (1)
3SHSA:214-295; A:214-295; A:214-295THREE N-TERMINAL DOMAINS OF THE BACTERIOPHAGE RB49 HIGHLY IMMUNOGENIC OUTER CAPSID PROTEIN (HOC)
(-)
Gallus gallus (Chicken) (1)
2VSDA:8-97CRYSTAL STRUCTURE OF CHIR-AB1
(-)
Homo sapiens (Human) (39)
3QQNB:111-117; B:111-117THE RETINAL SPECIFIC CD147 IG0 DOMAIN: FROM MOLECULAR STRUCTURE TO BIOLOGICAL ACTIVITY
3QR2B:111-117; B:111-117WILD TYPE CD147 IG0 DOMAIN
2PETA:1-112LUTHERAN GLYCOPROTEIN, N-TERMINAL DOMAINS 1 AND 2.
2PF6B:1-112; B:1-112LUTHERAN GLYCOPROTEIN, N-TERMINAL DOMAINS 1 AND 2
2NPLX:10-90NMR STRUCTURE OF CARD D2 DOMAIN
1OVZB:104-193; B:104-193; B:104-193; B:104-193CRYSTAL STRUCTURE OF HUMAN FCARI
1UCTA:105-195; A:105-195CRYSTAL STRUCTURE OF THE EXTRACELLULAR FRAGMENT OF FC ALPHA RECEPTOR I (CD89)
1RPQD:87-169; D:87-169; D:87-169; D:87-169; D:87-169; D:87-169; D:87-169; D:87-169HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY
2Y7QA:87-169; A:87-169THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI
1T83C:90-171; C:90-171CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)
1T89C:90-171; C:90-171CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)
1MQ8C:89-184; C:89-184CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
1P53B:378-447; B:378-447; B:378-447; B:378-447; B:378-447; B:378-447THE CRYSTAL STRUCTURE OF ICAM-1 D3-D5 FRAGMENT
1Z7ZI:378-447; I:378-447; I:378-447; I:378-447CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI
2OZ4A:378-447; A:378-447; A:378-447STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2QEJB:244-340; B:244-340CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1
3O4OB:130-213; B:130-213; C:120-215; C:120-215CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
3KGRC:28-120; C:28-120; C:28-120CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
3RP1D:28-120; D:28-120; D:28-120; D:28-120CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
2OTPB:5-93; B:5-93CRYSTAL STRUCTURE OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 1 (ILT1/LIR7/LILRA2)
1P7QD:5-95CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1UFUA:5-95CRYSTAL STRUCTURE OF LIGAND BINDING DOMAIN OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 2 (ILT2; LIR-1)
1UGNA:5-95CRYSTAL STRUCTURE OF LIR1.02, ONE OF THE ALLELES OF LIR1
1VDGB:5-95; B:5-95CRYSTAL STRUCTURE OF LIR1.01, ONE OF THE ALLELES OF LIR1
3P2TA:5-94CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR-5/CD85K)
1OLLA:4-93EXTRACELLULAR REGION OF THE HUMAN RECEPTOR NKP46
1P6FA:7-96STRUCTURE OF THE HUMAN NATURAL CYTOTOXICITY RECEPTOR NKP46
3P3YA:140-233; A:140-233CRYSTAL STRUCTURE OF NEUROFASCIN HOMOPHILIC ADHESION COMPLEX IN SPACE GROUP P6522
3P40A:140-233; A:140-233CRYSTAL STRUCTURE OF NEUROFASCIN ADHESION COMPLEX IN SPACE GROUP P3221
1WWWY:283-375; Y:283-375NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR
3MJGY:214-310; Y:214-310THE STRUCTURE OF A PLATELET DERIVED GROWTH FACTOR RECEPTOR COMPLEX
2L7UA:3-97STRUCTURE OF CEL-PEP-RAGE V DOMAIN COMPLEX
3O3UN:1023-1117CRYSTAL STRUCTURE OF HUMAN RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE)
3NVQE:546-629; E:546-629MOLECULAR MECHANISM OF GUIDANCE CUE RECOGNITION
1QSVA:137-229THE VEGF-BINDING DOMAIN OF FLT-1, 20 NMR STRUCTURES
1QSZA:137-229THE VEGF-BINDING DOMAIN OF FLT-1 (MINIMIZED MEAN)
1QTYY:137-225; Y:137-225; Y:137-225; Y:137-225VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR
1RV6Y:137-224; Y:137-224CRYSTAL STRUCTURE OF PLGF IN COMPLEX WITH DOMAIN 2 OF VEGFR1
2XACX:137-226; X:137-226STRUCTURAL INSIGHTS INTO THE BINDING OF VEGF-B BY VEGFR-1D2: RECOGNITION AND SPECIFICITY
(-)
Mus musculus (Mouse) (6)
1XAUA:14-113STRUCTURE OF THE BTLA ECTODOMAIN
3JZ7A:137-229CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF COXSACKIE & ADENOVIRUS RECEPTOR FROM MOUSE (MCAR)
3MJ7B:118-210CRYSTAL STRUCTURE OF THE COMPLEX OF JAML AND COXSACKIE AND ADENOVIRUS RECEPTOR, CAR
2O26Y:36-112; Y:36-112; Y:36-112; Y:36-112STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY
3RNKB:20-123CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MOUSE PD-1 MUTANT AND PD-L2 IGV DOMAIN
3RNQB:20-123CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND PD-L2
(-)
Rattus norvegicus (Rat) (1)
2WV3A:4-91NEUROPLASTIN-55 BINDS TO AND SIGNALS THROUGH THE FIBROBLAST GROWTH FACTOR RECEPTOR
(-)
Family: Ig_3 (11)
(-)
Ectromelia virus (1)
3OQ3B:230-314STRUCTURAL BASIS OF TYPE-I INTERFERON SEQUESTRATION BY A POXVIRUS DECOY RECEPTOR
(-)
Homo sapiens (Human) (9)
2OTPB:99-178; B:99-178CRYSTAL STRUCTURE OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 1 (ILT1/LIR7/LILRA2)
1P7QD:101-180CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1UFUA:101-180CRYSTAL STRUCTURE OF LIGAND BINDING DOMAIN OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 2 (ILT2; LIR-1)
1UGNA:101-180CRYSTAL STRUCTURE OF LIR1.02, ONE OF THE ALLELES OF LIR1
1VDGB:101-180; B:101-180CRYSTAL STRUCTURE OF LIR1.01, ONE OF THE ALLELES OF LIR1
3P2TA:100-176CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR-5/CD85K)
1OLLA:99-171EXTRACELLULAR REGION OF THE HUMAN RECEPTOR NKP46
1P6FA:102-174STRUCTURE OF THE HUMAN NATURAL CYTOTOXICITY RECEPTOR NKP46
1RHFB:102-167; B:102-167CRYSTAL STRUCTURE OF HUMAN TYRO3-D1D2
(-)
Mus musculus (Mouse) (1)
3RNQB:125-196CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND PD-L2
(-)
Family: Lep_receptor_Ig (2)
(-)
Homo sapiens (Human) (2)
1P9MA:2-92CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX
3L5HA:2-92CRYSTAL STRUCTURE OF THE FULL ECTODOMAIN OF HUMAN GP130: NEW INSIGHTS INTO THE MOLECULAR ASSEMBLY OF RECEPTOR COMPLEXES
(-)
Family: Receptor_2B4 (3)
(-)
Mus musculus (Mouse) (3)
1Z2KA:2-109NMR STRUCTURE OF THE D1 DOMAIN OF THE NATURAL KILLER CELL RECEPTOR, 2B4
2PTTB:3-109STRUCTURE OF NK CELL RECEPTOR 2B4 (CD244) BOUND TO ITS LIGAND CD48
2PTUD:3-110; D:3-110; D:3-110; D:3-110STRUCTURE OF NK CELL RECEPTOR 2B4 (CD244)
(-)
Family: V-set (144)
(-)
Branchiostoma floridae (Florida lancelet) (Amphioxus) (1)
1XT5A:5-131CRYSTAL STRUCTURE OF VCBP3, DOMAIN 1, FROM BRANCHIOSTOMA FLORIDAE
(-)
Ginglymostoma cirratum (Nurse shark) (2)
1SQ2N:2-112CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
1T6VO:2-112; O:2-112CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
(-)
Homo sapiens (Human) (61)
1Z9MB:37-137; B:37-137CRYSTAL STRUCTURE OF NECTIN-LIKE MOLECULE-1 PROTEIN DOMAIN 1
1YJDC:1-118CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
1QA9C:4-105; C:4-105STRUCTURE OF A HETEROPHILIC ADHESION COMPLEX BETWEEN THE HUMAN CD2 AND CD58(LFA-3) COUNTER-RECEPTORS
1JL4D:1-105CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
1RZJC:1-105HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
1WIPB:1-105; B:1-105STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM
1WIQB:1-105; B:1-105STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM
2NXYB:1001-1105; D:3002-3126; C:2002-2108HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NXZB:1001-1105HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY0B:1001-1105HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY1B:1001-1105; D:3004-3126; C:2002-2108HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY2B:1001-1105HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY3B:1001-1105; D:3004-3126; C:2002-2108HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY4B:1001-1105HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2NY5C:1001-1105HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2QADF:1-105; F:1-105STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
3JWDD:1001-1105; D:1001-1105STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3JWOC:1001-1105STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3LQAC:2-105CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
3KG5B:43-142; B:43-142CRYSTAL STRUCTURE OF HUMAN IG-BETA HOMODIMER
1NCNB:1-105; B:1-105THE RECEPTOR-BINDING DOMAIN OF HUMAN B7-2
3QZWJ:1-110; J:1-110; J:1-110; J:1-110PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
2QSTB:1-106; B:1-106CRYSTAL STRUCTURE OF THE V39C MUTANT OF THE N-TERMINAL DOMAIN OF CARCINOEMBRYONIC ANTIGEN (CEA)
2VERN:1-106STRUCTURAL MODEL FOR THE COMPLEX BETWEEN THE DR ADHESINS AND CARCINOEMBRYONIC ANTIGEN (CEA)
2NMSA:21-125THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
2Q87C:5-108; C:5-108; C:5-108THE CRYSTAL STRUCTURE OF THE HUMAN IRP60 ECTODOMAIN
3RBGD:18-114; D:18-114; D:18-114; D:18-114CRYSTAL STRUCTURE ANALYSIS OF CLASS-I MHC RESTRICTED T-CELL ASSOCIATED MOLECULE
2X44D:2-116STRUCTURE OF A STRAND-SWAPPED DIMERIC FORM OF CTLA-4
3OSKB:3-116; B:3-116CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
1KACB:24-139KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12 IN COMPLEX WITH DOMAIN 1 OF ITS CELLULAR RECEPTOR CAR
1P69B:24-139STRUCTURAL BASIS FOR VARIATION IN ADENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (P417S MUTANT)
1P6AB:24-139STRUCTURAL BASIS FOR VARIATION IN ASDENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (S489Y MUTANT)
1RSFA:21-137NMR STRUCTURE OF MONOMERIC CAR D1 DOMAIN
2W9LZ:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135; Z:19-135CANINE ADENOVIRUS TYPE 2 FIBRE HEAD IN COMPLEX WITH CAR DOMAIN D1 AND SIALIC ACID
3NOIB:18-127; B:18-127CRYSTAL STRUCTURE OF NATURAL KILLER CELL CYTOTOXICITY RECEPTOR NKP30 (NCR3)
3PV6B:19-127CRYSTAL STRUCTURE OF NKP30 BOUND TO ITS LIGAND B7-H6
1XEDF:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109; F:107-109CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR, PIGR
2NW2A:1-114CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
1JVKB:3-110; B:3-110THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
3MNZA:32-106CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION
1PW3B:1-106; B:1-106CRYSTAL STRUCTURE OF JTOR68S
1T2JA:2-107CRYSTAL STRUCTURE OF A HUMAN VH DOMAIN
2JJSB:3-113; B:3-113STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJTB:3-113; B:3-113STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2UV3B:3-113; B:3-113STRUCTURE OF THE SIGNAL-REGULATORY PROTEIN (SIRP) ALPHA DOMAIN THAT BINDS CD47.
2WNGA:3-113COMPLETE EXTRACELLULAR STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2ZG1A:26-144CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF SIGLEC-5 IN COMPLEX WITH 6'-SIALYLLACTOSE
2ZG2A:26-144CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
2ZG3A:26-144CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3'-SIALYLLACTOSE
1NKOA:25-145ENERGETIC AND STRUCTURAL BASIS OF SIALYLATED OLIGOSACCHARIDE RECOGNITION BY THE NATURAL KILLER CELL INHIBITORY RECEPTOR P75/AIRM1 OR SIGLEC-7
1O7SA:25-144HIGH RESOLUTION STRUCTURE OF SIGLEC-7
1O7VA:25-144HIGH RESOLUTION STRUCTURE OF SIGLEC-7
2JJUB:3-114; B:3-114STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA
2JJVB:3-114; B:3-114STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA(2)
2JJWA:4-112STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) GAMMA
3Q0HB:25-126; B:25-126STRUCTURE OF T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS (TIGIT)
3RQ3B:23-126; B:23-126STRUCTURE OF T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS (TIGIT) IN HEXAGONAL CRYSTAL FORM
1Q8MD:20-133; D:20-133; D:20-133; D:20-133CRYSTAL STRUCTURE OF THE HUMAN MYELOID CELL ACTIVATING RECEPTOR TREM-1
1SMOB:26-133; B:26-133CRYSTAL STRUCTURE OF HUMAN TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.47 .
2X1WO:225-324; O:225-324; O:225-324; O:225-324CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2
2X1XR:225-324CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM
(-)
Ictalurus punctatus (Channel catfish) (3)
2QQQD:3-111; D:3-111; D:3-111; D:3-111CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 11 EXTRACELLULAR FRAGMENT FROM ICTALURUS PUNCTATUS
2QHLE:2-111; E:2-111; E:2-111; E:2-111; E:2-111CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 10 EXTRACELLULAR FRAGMENT FROM ICTALURUS PUNCTATUS
2QJDB:3-111; B:3-111CRYSTAL STRUCTURE OF NOVEL IMMUNE-TYPE RECEPTOR 10 EXTRACELLULAR FRAGMENT MUTANT N30D
(-)
Lama glama (Llama) (3)
2P49B:1-119COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.4A RESOLUTION: NATIVE MONO_1 CRYSTAL FORM
2P4AD:1-119; D:1-119X-RAY STRUCTURE OF A CAMELID AFFINITY MATURED SINGLE-DOMAIN VHH ANTIBODY FRAGMENT IN COMPLEX WITH RNASE A
1QD0A:1-126CAMELID HEAVY CHAIN VARIABLE DOMAINS PROVIDE EFFICIENT COMBINING SITES TO HAPTENS
(-)
Mus musculus (Mouse) (63)
2OJZM:3-106; M:3-106ANTI-DNA ANTIBODY ED10
2OK0L:3-106FAB ED10-DNA COMPLEX
3M45D:35-131; D:35-131; D:35-131; D:35-131CRYSTAL STRUCTURE OF IG1 DOMAIN OF MOUSE SYNCAM 2
2PTTA:5-102STRUCTURE OF NK CELL RECEPTOR 2B4 (CD244) BOUND TO ITS LIGAND CD48
2PTVA:5-102STRUCTURE OF NK CELL RECEPTOR LIGAND CD48
3KHOB:43-141; B:43-141CRYSTAL STRUCTURE OF MURINE IG-BETA (CD79B) HOMODIMER
1L6ZA:1-106CRYSTAL STRUCTURE OF MURINE CEACAM1A[1,4]: A CORONAVIRUS RECEPTOR AND CELL ADHESION MOLECULE IN THE CEA FAMILY
1ZOXA:1-107CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
3JZ7A:25-146CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF COXSACKIE & ADENOVIRUS RECEPTOR FROM MOUSE (MCAR)
3MJ7B:3-127CRYSTAL STRUCTURE OF THE COMPLEX OF JAML AND COXSACKIE AND ADENOVIRUS RECEPTOR, CAR
2OR8B:2-110; B:2-110TIM-1
3KAAB:10-110; B:10-110STRUCTURE OF TIM-3 IN COMPLEX WITH PHOSPHATIDYLSERINE
1QNZH:114-210; L:1-110NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE
1NQBC:2-118; C:2-118TRIVALENT ANTIBODY FRAGMENT
1MCPH:2-120PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
2MCPH:2-120REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
1P4BH:7-106; L:2-136THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P).
1P4IH:2-106; L:2-136CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4
1MQKH:1-96; L:11-107CRYSTAL STRUCTURE OF THE UNLIGANDED FV-FRAGMENT OF THE ANTI-CYTOCHROME C OXIDASE ANTIBODY 7E2
1UB5H:2-99; H:2-99CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH HAPTEN AT 100K
1KCSH:7-98CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1KCVH:7-98CRYSTAL STRUCTURE OF ANTIBODY PC282
1MAJA:1-111SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
1MAKA:1-111SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
1SVZB:4-111; B:4-111CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-2 PROTEASE
1QBLL:1-95FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
1Q0XL:2-91ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
1Q0YL:2-106; H:2-111ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
1PY9A:2-115THE CRYSTAL STRUCTURE OF AN AUTOANTIGEN IN MULTIPLE SCLEROSIS
1NPUA:1-112CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1
3RNKA:34-145CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MOUSE PD-1 MUTANT AND PD-L2 IGV DOMAIN
3RNQA:34-145CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND PD-L2
2OYPA:24-129T CELL IMMUNOGLOBULIN MUCIN-3 CRYSTAL STRUCTURE REVEALED A GALECTIN-9-INDEPENDENT BINDING SURFACE
3R4DC:1-106; C:1-106CRYSTAL STRUCTURE OF MOUSE CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS MURINE RECEPTOR
1NBZB:403-411CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
3OZ9H:2-111; L:1-106CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
1MPAH:1-119BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
2MPAH:1-119BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
1U3HE:2-93; E:2-93; F:3-116; F:3-116CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
2OL3A:1-93; B:2-96CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
2PXYA:1-93CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
2Z31A:1-93CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
2Z35A:1-93CRYSTAL STRUCTURE OF IMMUNE RECEPTOR
1JN6B:2-117CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1XGYI:1-111; I:1-111CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42-41L
1YNLH:2-110IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
1JGLL:1-106CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
1JNLL:4-106; H:2-112CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1JNNL:4-106; H:2-112CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
1QOKA:164-266MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY
1JGUH:1-111STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1JGVH:1-111STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4
1T66H:1-116; H:1-116THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
2YZ1B:7-119; B:7-119CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF MURINE SHPS-1/SIRP ALPHA
1OD7A:1-116N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC (NAP COMPOUND)
1OD9A:1-116N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-BENZOYL-AMINO-9-DEOXY-NEU5AC (BENZ COMPOUND)
1ODAA:1-116N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N-(BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC (BIP COMPOUND)
1QFOC:1-116; C:1-116; C:1-116N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH 3'SIALYLLACTOSE
1URLA:1-116N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH GLYCOPEPTIDE
2OR7B:2-109; B:2-109TIM-2
1U9KB:25-133; B:25-133CRYSTAL STRUCTURE OF MOUSE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM-1) AT 1.76
2OI9B:1-114STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX
1KB5B:2-116MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
(-)
Orectolobus maculatus (spotted wobbegong) (7)
2YWYD:1-110; D:1-110; D:1-110; D:1-110STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2YWZA:1-110STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1VESB:1-112; B:1-112STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2Z8VD:1-112; D:1-112STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2Z8WD:1-112; D:1-112STRUCTURE OF AN IGNAR-AMA1 COMPLEX
3MOQD:1-123; D:1-123; D:1-123; D:1-123AMYLOID BETA(18-41) PEPTIDE FUSION WITH NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1VERA:1-110STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
(-)
Rattus norvegicus (Rat) (4)
1T6WA:1-95RATIONAL DESIGN OF A CALCIUM-BINDING ADHESION PROTEIN NMR, 20 STRUCTURES
1PKQJ:2-115; J:2-115MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
1NEUA:1-117STRUCTURE OF MYELIN MEMBRANE ADHESION MOLECULE P0
1ZANL:1-106CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
(-)
Family: V-set_CD47 (3)
(-)
Homo sapiens (Human) (3)
2JJSD:2-116; D:2-116STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2JJTD:2-115; D:2-115STRUCTURE OF HUMAN CD47 IN COMPLEX WITH HUMAN SIGNAL REGULATORY PROTEIN (SIRP) ALPHA
2VSCD:2-116; D:2-116; D:2-116; D:2-116STRUCTURE OF THE IMMUNOGLOBULIN-SUPERFAMILY ECTODOMAIN OF HUMAN CD47
(-)
Family: ig (14)
(-)
Homo sapiens (Human) (11)
3QS7H:265-332; H:265-332; H:265-332; H:265-332CRYSTAL STRUCTURE OF A HUMAN FLT3 LIGAND-RECEPTOR TERNARY COMPLEX
3QS9H:265-332; H:265-332; H:265-332; H:265-332CRYSTAL STRUCTURE OF A HUMAN FLT3 LIGAND-RECEPTOR TERNARY COMPLEX
3O4OC:238-315CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
1NKRA:121-179; A:121-179INHIBITORY RECEPTOR (P58-CL42) FOR HUMAN NATURAL KILLER CELLS
3MJGY:47-102; Y:47-102THE STRUCTURE OF A PLATELET DERIVED GROWTH FACTOR RECEPTOR COMPLEX
2V5YA:179-242CRYSTAL STRUCTURE OF THE RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU ECTODOMAIN
1OLZB:548-605; B:548-605THE LIGAND-BINDING FACE OF THE SEMAPHORINS REVEALED BY THE HIGH RESOLUTION CRYSTAL STRUCTURE OF SEMA4D
3OL2A:569-626RECEPTOR-LIGAND STRUCTURE OF HUMAN SEMAPHORIN 4D WITH PLEXIN B1.
2ZG1A:162-220CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF SIGLEC-5 IN COMPLEX WITH 6'-SIALYLLACTOSE
2ZG2A:162-220CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
2ZG3A:162-220CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3'-SIALYLLACTOSE
(-)
Mus musculus (Mouse) (3)
1NEZH:19-104; H:19-104THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION, CO-RECEPTOR PREFERENCE AND AFFINITY
1L6ZA:125-182CRYSTAL STRUCTURE OF MURINE CEACAM1A[1,4]: A CORONAVIRUS RECEPTOR AND CELL ADHESION MOLECULE IN THE CEA FAMILY
3R4DC:125-182; C:125-182CRYSTAL STRUCTURE OF MOUSE CORONAVIRUS RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS MURINE RECEPTOR